ÂÜÀòÂÒÂ×

Guoxiang Shen, Ph.D., currently serves as Vice President of Global Clinical Pharmacology at ADC Therapeutics, a position held since June 2024. Prior to this role, Guoxiang Shen was Executive Director and Head of Clinical Pharmacology at BioAtla, Inc. from May 2022 to June 2024. Earlier experience includes serving as a Senior Clinical Pharmacology Reviewer in the Division of Cancer Pharmacology at the FDA from August 2015 to May 2022, and as Associate Director and Senior Fellow in Clinical Pharmacokinetics at Novartis Oncology from June 2011 to August 2015. Additional experience includes a tenure as a Senior Research Investigator in DMPK at Bristol-Myers Squibb from August 2006 to June 2011. Guoxiang Shen earned a Doctor of Philosophy in Pharmaceutical Sciences from Rutgers University, completing the program from 2001 to 2006.